Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Meribel Pharma Sweden AB
AB
Active
Org 5594561473
Gårdsvägen 10 A, 169 70
Solna
Activities of head offices
· NACE 7010
Est. 2023
0 employees
Watchlist
Share
Sweden
/
Companies
/
Activities of head offices
/
Meribel Pharma Sweden AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
9M
17M
26M
35M
30M
2024
EBITDA
SEK millions
0M
3M
5M
8M
10M
9M
2024
Income statement
SEK thousands
Item
2024
Revenue
29 564
Staff expenses
—
EBITDA
8 659
Depreciation & amort.
−9 821
EBIT
−1 162
Net financials
−8 588
Profit before tax
−1 469
Tax
−0
Net profit
−1 469
Balance sheet
SEK thousands
Item
2024
Total assets
1 181 320
Equity
961 759
Long-term debt
35
Short-term debt
219 525
Total debt
219 560
Financial ratios
5-year trend
EBITDA margin
29.3%
This company
15.8%
Market median
+85% vs market
2024
2024
Equity ratio
81.4%
This company
38.2%
Market median
+113% vs market
2024
2024
Return on equity
-0.2%
This company
18.4%
Market median
-101% vs market
2024
2024
Net profit margin
-5.0%
This company
8.1%
Market median
-162% vs market
2024
2024
Asset turnover
0.03×
This company
1.12×
Market median
-97% vs market
2024
2024
Debt / equity
0.23×
This company
0.62×
Market median
+63% vs market
2024
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2023-11-01 – 2024-12-31
View
PDF
More on Meribel Pharma Sweden AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
